The Health Council of Netherlands recommends that as much as possible the BioNTech/Pfizer should be reserved for people aged 60 and above and that vaccination should start with the oldest age group. This is in keeping with the Council’s previous advisory report on vaccination strategies. A limited amount of vaccine could be used to vaccinate care workers, in order to protect vulnerable elderly people and to safeguard the continuity of healthcare. The Committee believes that care workers in general could be vaccinated using the AstraZeneca vaccine. Current projections show that large quantities of this vaccine could be delivered in the first quarter of 2021.

  • Recommendation
  • Europe
  • Netherlands
  • Pfizer-BioNTech vaccine
  • COVID-19